Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$111,656
in 2 filings

Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 47 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-08-20 WITTE OWEN N. Director Sale −5,000 $23.24 $116K 226,182
2021-08-16 Bhavnagri Veer General Counsel Option exercise +5,000 $2.27 $11K 426,353
2021-08-16 Bhavnagri Veer General Counsel Sale −5,000 $21.00 $105K 421,353
2021-08-16 Bhavnagri Veer General Counsel Option exercise · Stock Option (Right to Buy) −5,000 117,300
2021-07-30 SATO VICKI L Director Grant or award +19,362 19,362
2021-07-30 SATO VICKI L Director Grant or award · Stock Option (Right to Buy) +31,692 31,692
2021-07-30 Barrett Elizabeth A. Director Grant or award · Stock Option (Right to Buy) +63,385 63,385
2021-07-15 Bhavnagri Veer General Counsel Option exercise +5,000 $2.27 $11K 426,353
2021-07-15 Bhavnagri Veer General Counsel Sale −5,000 $21.55 $108K 421,353
2021-07-15 Bhavnagri Veer General Counsel Option exercise · Stock Option (Right to Buy) −5,000 122,300
2021-06-15 Bhavnagri Veer General Counsel Option exercise +5,000 $2.27 $11K 426,353
2021-06-15 Bhavnagri Veer General Counsel Sale −5,000 $25.32 $127K 421,353
2021-06-15 Bhavnagri Veer General Counsel Option exercise · Stock Option (Right to Buy) −5,000 127,300
2021-06-11 Kazam Joshua A Director Gift −500,000 243,885
2021-06-10 WITTE OWEN N. Director Grant or award · Stock Option (Right to Buy) +28,015 28,015
2021-06-10 MESSEMER DEBORAH M. Director Grant or award · Stock Option (Right to Buy) +28,015 28,015
2021-06-10 Humer Franz B Director Grant or award +16,498 147,714
2021-06-10 Kazam Joshua A Director Grant or award +16,498 743,885
2021-06-09 WITTE OWEN N. Director Sale −9,969 $25.05 $250K 236,182
2021-05-24 Chang David D President and CEO Option exercise +27,410 $18.22 $499K 2,312,279

Page 11 of 18 · 348 trades